Men's Health · August 2026 · 8 min read

Erectile Dysfunction After 50: What's Normal, What Isn't, and What Actually Works

By Dr Kishore Bahl BSc MBBS — Specialist Grade Doctor in Urology, Shockwave ReVibe Clinic, Notting Hill Gate, London

One of the most common things I hear from men over 50 who come to see me about erectile dysfunction is a version of the same sentence: "I assumed it was just part of getting older."

It is not. And this assumption — more than any other single factor — is what keeps men managing a treatable condition in silence for years longer than necessary.

ED does become more common with age. But common is not the same as inevitable, and more common is not the same as untreatable. The majority of men over 50 who experience erectile dysfunction have an identifiable cause — and in most cases, an effective treatment. The biology of ageing changes the context of ED; it does not change the fundamental fact that the condition responds to appropriate clinical management. For the full breakdown of every cause, see our guide to erectile dysfunction causes.

This guide addresses what actually changes after 50, why ED becomes more prevalent, what is and is not normal, and what the evidence shows about treatment in this age group. For an overview of the full treatment pathway, see our Erectile Dysfunction Treatment London service page.

"Common is not the same as inevitable, and more common is not the same as untreatable."

What Changes After 50

Several physiological changes associated with ageing directly affect erectile function. Understanding these is important — not to accept them as inevitable, but to understand what appropriate treatment needs to address.

Testosterone Decline

Testosterone — the primary driver of male sexual desire — declines gradually from around age 30, at approximately 1-2% per year. By the age of 50, many men have testosterone levels meaningfully lower than they did at 30. By 60, the decline is clinically significant in a substantial minority.

Low testosterone does not directly cause most ED — its primary effect is on libido (sexual desire) rather than erectile mechanism. However, reduced desire means reduced sexual activity, which in turn reduces the frequency of erections and the associated tissue oxygenation that maintains erectile tissue health. In this indirect way, testosterone decline contributes to the progressive vascular changes in the penile tissue that drive vasculogenic ED. Where testing confirms a deficiency, see our Low Libido & Sexual Wellness service.

Vascular Changes

The most significant driver of ED after 50 is vascular. The same atherosclerotic process responsible for cardiovascular disease — endothelial dysfunction, arterial stiffening, reduced nitric oxide production — progressively affects the penile arteries. Because the penile arteries are small (approximately 1-2mm in diameter), they develop these changes earlier and more noticeably than larger vessels.

This is why erectile dysfunction is now recognised as an early warning sign of cardiovascular disease. A meta-analysis published in Circulation found that men with ED have a 44% increased risk of cardiovascular events — and that ED typically precedes cardiac symptoms by three to five years. (Vlachopoulos C et al., Circulation, 2010) In men over 50 with cardiovascular risk factors, this relationship is particularly important.

Slower Nerve Response

The nerve pathways responsible for initiating the erectile reflex become less sensitive with age. The time between stimulation and erection increases. This is normal — but it is frequently misinterpreted as ED when it is actually a change in response speed rather than a failure of erectile function. Many men over 50 benefit from understanding this distinction before concluding that something is clinically wrong.

Medication Load

Men over 50 are significantly more likely to be on regular medications — antihypertensives, statins, antidepressants, alpha-blockers — many of which can cause or worsen erectile dysfunction. This is one of the most commonly overlooked contributors to ED in this age group.

What's Normal After 50 — and What Isn't

This distinction matters clinically.

Normal age-related changes:

  • Longer time to achieve erection after stimulation
  • Erections that are slightly less firm than at 30
  • Longer refractory period (time before another erection is possible)
  • Reduced spontaneous erections

Not normal — and worth assessing:

  • Consistent inability to achieve or maintain an erection sufficient for intercourse
  • Complete absence of morning erections
  • Significant, sudden change in erectile function
  • ED associated with reduced libido, fatigue, and mood changes (possible hormonal cause)
  • ED that begins or worsens after starting a new medication

The key clinical distinction is between age-related changes in response speed and firmness (which are normal and do not require treatment unless they are causing distress) and progressive inability to achieve or maintain adequate erections (which warrants proper assessment regardless of age).

How Common Is ED After 50?

The prevalence data is well established. The Massachusetts Male Aging Study — one of the largest epidemiological studies of male sexual function — found:

40%
Of men experience some degree of ED at age 40
50%
At age 50
60%
At age 60
70%
At age 70 (Feldman HA et al., 1994)

These figures are often cited as evidence that ED is inevitable with age. They are not. They show that ED becomes more common — which reflects the accumulation of vascular risk factors, medication burden, and hormonal change over time. None of these are fixed. All of them are to varying degrees modifiable.

Why ED After 50 Is Often Undertreated

Several factors combine to make ED in men over 50 chronically undertreated:

The normalisation of ageing. Men and their partners frequently accept declining sexual function as an inevitable consequence of getting older — not recognising that in most cases it has a specific, addressable cause.

Embarrassment. Despite its prevalence, ED remains one of the conditions men are least likely to raise with their GP unprompted. A 10-minute appointment does not create the environment for this conversation.

The cardiovascular link goes unrecognised. Most men over 50 with ED are not told that their erectile dysfunction may be the earliest signal of vascular disease affecting their heart. This missed connection means the ED is managed in isolation — often with medication only — rather than as part of a broader cardiovascular health picture.

Medication is offered without assessment. Many men over 50 are prescribed PDE5 inhibitors (Viagra, Cialis) without any investigation of the underlying cause. For some this is sufficient. For others — particularly those with hormonal causes or significant vascular disease — it addresses the symptom without touching the cause.

What Actually Works for ED After 50

Focal Shockwave Therapy

For vasculogenic ED — which accounts for the majority of ED in men over 50 — focal shockwave therapy is the most clinically appropriate treatment available beyond medication. It addresses the vascular root cause rather than working around it.

Low-intensity focal shockwave therapy (Li-ESWT) stimulates biological regeneration in the penile arterial tissue — promoting angiogenesis (new blood vessel growth), endothelial repair, and improved nitric oxide production. Results persist after the treatment course ends because they reflect genuine tissue-level change, not a pharmacological effect.

A 2017 meta-analysis of 14 randomised controlled trials involving 833 patients confirmed significant improvement in erectile function scores and penile haemodynamics following Li-ESWT. (Lu Z et al., International Journal of Impotence Research, 2017) Critically, studies consistently show maintained improvement at 12-24 month follow-up — making this particularly relevant for men over 50 who want durable results rather than ongoing medication dependency.

For men who have stopped responding to PDE5 inhibitors — which is more common after 50 as vascular damage accumulates — a 2014 study found that 57% achieved successful intercourse following focal shockwave therapy, suggesting the treatment can restore vascular function to the point where medication becomes effective again. (Gruenwald I et al., Journal of Sexual Medicine, 2014)

The European Association of Urology formally recognises Li-ESWT as a therapeutic option for vasculogenic ED in its 2024 guidelines.

PDE5 Inhibitors

PDE5 inhibitors (Viagra, Cialis, Levitra) remain appropriate and effective for many men over 50. Response rates are somewhat lower in this age group than in younger men — approximately 60-70% versus 70-80% in unselected populations — reflecting the greater degree of vascular damage. (Hatzimouratidis K et al., European Urology, 2010)

Important considerations after 50: nitrate medications (commonly prescribed for cardiovascular conditions) are an absolute contraindication to all PDE5 inhibitors. This affects a significant proportion of men over 60 with established cardiovascular disease — for whom focal shockwave therapy is the appropriate alternative. Cardiac risk assessment before starting PDE5 inhibitors is advisable in men with significant cardiovascular disease. Dose may need adjustment — some men over 50 find that lower doses are sufficient; others find standard doses less effective as vascular disease progresses.

Testosterone Management

Where blood testing confirms testosterone deficiency — which becomes more common with age — hormonal management can restore libido and contribute to improved erectile function, particularly in combination with other treatments.

Blood testing is essential before any testosterone management. Testosterone levels in the low-normal range may not warrant treatment; confirmed deficiency with associated symptoms does.

Lifestyle Modification

The evidence for lifestyle modification in ED after 50 is compelling and frequently underemphasised. A 2004 JAMA study found that lifestyle intervention in obese men with ED produced significant improvement in erectile function — with one third recovering normal function without any specific ED treatment. (Esposito K et al., JAMA, 2004)

Key interventions with evidence:

  • Weight loss — reduces cardiovascular risk, increases testosterone, improves endothelial function
  • Regular aerobic exercise — directly improves endothelial function and erectile function (Gerbild H et al., Sexual Medicine, 2018)
  • Smoking cessation — reduces vascular damage and improves response to treatment
  • Alcohol moderation — chronic heavy use suppresses testosterone and damages vascular endothelium
  • Blood pressure and cholesterol control — directly addresses the vascular mechanism of ED

The Cardiovascular Assessment Every Man Over 50 Should Have

This is the conversation that happens too rarely in ED management after 50.

Erectile dysfunction in a man over 50 with cardiovascular risk factors — high blood pressure, high cholesterol, obesity, smoking history, family history of heart disease — is not simply a sexual health concern. It is a potential early marker of systemic vascular disease. The penile arteries develop atherosclerotic changes earlier than coronary arteries because they are smaller. In this sense, the penis is a sentinel organ for cardiovascular health.

A Comprehensive ED Assessment After 50 Should Include

  • Cardiovascular risk factor review — blood pressure, lipid profile, glucose, BMI
  • Discussion of family history
  • Where appropriate, referral for cardiovascular assessment

This is what I do at Shockwave ReVibe Clinic. The ED assessment is not a siloed sexual health appointment — it is a clinical evaluation that takes the full picture seriously, delivered through a men's urology consultation.

Dr Kishore Bahl

Every ED assessment at Shockwave ReVibe Clinic is carried out personally by Dr Bahl — including the cardiovascular risk review too many ED consultations skip. Read our complete guide to ED treatment →

GMC: 6070860 Specialist Grade Doctor in Urology 30 Years Medical Experience 20+ Years NHS 15 Years Urology Wexham Park · Royal London · Hillingdon

Frequently Asked Questions

Is erectile dysfunction normal after 50?

ED becomes more common after 50 — affecting approximately 50% of men at this age. However, common is not the same as inevitable or untreatable. In most men over 50 with ED, there is an identifiable cause — most commonly vascular — that responds to appropriate treatment.

Does shockwave therapy work for ED in older men?

Yes. Clinical trials for focal shockwave therapy in ED include men across a wide age range, and results are not significantly inferior in older men. The biological regeneration process — angiogenesis and endothelial repair — occurs regardless of age, though the degree of vascular damage at baseline affects the magnitude of response.

Can I take Viagra if I'm on heart medication?

It depends on which heart medication. Nitrates — including GTN spray — are an absolute contraindication to all PDE5 inhibitors (Viagra, Cialis, Levitra). This is clinically significant for men over 60 with established cardiovascular disease. Focal shockwave therapy has no drug interactions and is safe in men on nitrates.

Is ED after 50 a sign of heart disease?

It can be. Men over 50 with ED and cardiovascular risk factors should have a cardiovascular risk assessment as part of their ED evaluation. ED frequently precedes cardiac symptoms by three to five years in men with underlying vascular disease.

Do I need a GP referral to see a specialist privately?

No. At Shockwave ReVibe Clinic you can book directly without a GP referral. Initial consultation: £59. No waiting list.

What is the most effective treatment for ED after 50?

This depends on the cause. For vascular ED — the most common cause in this age group — focal shockwave therapy addresses the underlying pathology and produces durable improvement lasting 12-24 months. PDE5 inhibitors are effective symptomatically. Lifestyle modification is underutilised and produces meaningful improvement in many men. A proper specialist assessment establishes which approach is most appropriate for your specific situation.

Clinical References

  1. Feldman HA et al. (1994). Impotence and its medical and psychosocial correlates. Journal of Urology, 151(1): 54-61.
  2. Vlachopoulos C et al. (2010). Prediction of cardiovascular events and all-cause mortality with erectile dysfunction. Circulation, 121(22): 2377-2385.
  3. Lu Z et al. (2017). Low-intensity extracorporeal shock wave treatment improves erectile dysfunction. International Journal of Impotence Research, 29(3): 95-99.
  4. Gruenwald I et al. (2014). Shockwave treatment of erectile dysfunction. Therapeutic Advances in Urology, 5(2): 95-99.
  5. Hatzimouratidis K et al. (2010). Guidelines on male sexual dysfunction. European Urology, 57(5): 804-814.
  6. Esposito K et al. (2004). Effect of lifestyle changes on erectile dysfunction in obese men. JAMA, 291(24): 2978-2984.
  7. Gerbild H et al. (2018). Physical activity to improve erectile function. Sexual Medicine, 6(2): 75-89.
  8. European Association of Urology (2024). EAU Guidelines on Sexual and Reproductive Health. EAU Guidelines Office, Arnhem, The Netherlands.

Dr Kishore Bahl is a Specialist Grade Doctor in Urology (GMC Registration: 6070860) and founder of Shockwave ReVibe Clinic, 22 Notting Hill Gate, London W11 3JE. To book a consultation, call 020 3004 0564 or visit shockwave-revibe.co.uk.

Last reviewed: August 2026

Ready to Find Out What's Really Going On?

Book your ED assessment with Dr Bahl at our Notting Hill Gate clinic — including the cardiovascular review most consultations skip. No obligation, fully confidential.

Book a Consultation

By booking an appointment you agree to our Privacy Policy